Hans Thoenen

Title: The Innovations of Hans Thoenen

Introduction

Hans Thoenen is a notable inventor based in Munich, Germany. He has made significant contributions to the field of neurobiology, particularly in the development of neurotrophic factors. With a total of 6 patents, his work has paved the way for advancements in the treatment of neurological disorders.

Latest Patents

One of Hans Thoenen's latest patents is focused on methods of treating peripheral neuropathies using neurotrophin-3 (NT-3). This invention relates to NT-3, a newly discovered member of the BDNF gene family. The patent outlines the identification of regions of nucleic acid sequence homology shared by BDNF and NGF, which can be used to identify new members of the BDNF/NGF gene family. The invention provides for the genes and gene products of new BDNF/NGF related neurotrophic factors identified by these methods. NT-3 may be utilized in the diagnosis and treatment of neurologic disorders, including Alzheimer's disease and Parkinson's disease. The unique activity spectrum of NT-3 offers valuable options for inducing regrowth and repair in the central nervous system.

Career Highlights

Throughout his career, Hans Thoenen has worked with prominent organizations such as Regeneron Pharmaceuticals, Inc. and the Max Planck Society for the Advancement of Science. His research has significantly impacted the understanding of neurotrophic factors and their applications in medicine.

Collaborations

Hans Thoenen has collaborated with esteemed colleagues, including Yves-Alain Barde and Friedrich Lottspeich. These partnerships have contributed to the advancement of research in neurobiology and the development of innovative treatments.

Conclusion

Hans Thoenen's contributions to the field of neurobiology through his patents and collaborations have made a lasting impact on the treatment of neurological disorders. His work continues to inspire future innovations in the medical field.